Explaining a capital decision so investors can judge it

Plans and capital-allocation policies usually make the economic case: 85 of 106 rate 4–5 on economics, and a stated cost of capital or hurdle rate is common. Single decisions (buybacks, acquisitions, dividends and the rest) rarely do: 15 of 28 rate 0–2, and only one rates 4–5. The test set out in the plan is seldom used to explain the decisions made under it. On follow-through, 113 actions are not yet due and 13 could be rated.

What a clear explanation contains

• The limit in money or shares, and the period
• The method (market purchases, ToSTNeT, tender offer and so on)
• What happens to the shares bought (cancelled, held, and for what)
• For a plan: the numerical targets, the deadline and the assumptions

Examples of a clear explanation

• Kissei Pharmaceutical Co., Ltd. 4547 — The notice issued before the purchase gives the share and value limits, the price, the venue and session time, and the number and date of the shares to be cancelled. Document ↗ · reviewed 2026-10-21
• GNI Group Ltd. 2160 — The share-issue notice gives the share count, how the price is set, the dates, and the use of the proceeds by amount, purpose and deadline, with what happens if a use falls through. Document ↗ · reviewed 2026-10-21

Common gaps (no company named)

• A stated policy with no date or definition: "promptly", "over the medium to long term".

What a clear explanation contains

• Interim notices (such as monthly buyback status) that give both the period and the cumulative figures
• On completion, the result set against the limits in the resolution
• For an acquisition: decision, funding, payment, completion and consolidation dated and reconciled

Examples of a clear explanation

• TSUMURA & CO. 4540 — Monthly status notices give the month's and the cumulative shares and cost, and the completion notice reconciles to the resolution: 1,237,700 shares for ¥4,999,977,000. Document ↗ · reviewed 2026-10-20

Common gaps (no company named)

• A completion that is reported, but not against the original limit or plan.

What a clear explanation contains

• Why this use of the cash beats the alternatives (investment, debt repayment, dividends, holding it)
• The test applied (hurdle rate, cost of capital, ROIC) and its number
• For an acquisition or licence: price, the target's results, the expected effect and when, and the funding
• For a buyback: price discipline, or the effect on EPS or ROE

Examples of a clear explanation

• Yokogawa Electric Corporation 6841 — Investment thresholds are set above a stated cost of capital of 7–9%, with the balance-sheet capacity shown. Document ↗ · reviewed 2026-09-28
• Nippon Sanso Holdings Corporation 4091 — Hurdle rates are given by region, with their periodic review and the funding priorities. Document ↗ · reviewed 2026-09-24
• Towa Pharmaceutical Co., Ltd. 4553 — The funding notice compares ordinary shares, preferred shares and debt and states the cost of the route chosen (4.4%). One of the few single decisions that addresses its economics. Document ↗ · reviewed 2026-10-20

Common gaps (no company named)

• A licence with no financial term disclosed at all.
• An acquisition with the price or the target's sales, but no expected return and no funding source.
• A buyback explained only as "improving capital efficiency", with no price discipline or effect.
• Capacity spending with the cost and the capacity, but no expected sales, margin or payback.
• A dividend increase explained only by "performance and other factors".
• A plan that states a cost of capital or hurdle rate that is then not used to explain the single decisions under it.

What a clear explanation contains

• When the deadline arrives, the original target set against the result
• If it was missed, why, and what happens next
• If the target was revised, the old and the new target, and why

Examples of a clear explanation

• Kaken Pharmaceutical Co., Ltd. 4521 — The result notices show the full share limit bought within seven weeks under the value limit, and the cancellation completed on the planned date. Document ↗ · reviewed 2026-10-21
• Riken Keiki Co., Ltd. 7734 — For the completed plan, it reports sales and operating profit above the plan thresholds, with the business and regional drivers. Document ↗ · reviewed 2026-09-30

Common gaps (no company named)

• A revised target, with no result set against the original one.

1. What was decided: the amount, shares, price, period and method.
2. Why this use of the cash: why it beats the alternatives, and the test used (cost of capital, hurdle rate, ROIC).
3. The numbers: for an acquisition, the price, the target's results, the expected effect and when, and the funding; for a buyback, the price discipline or the per-share effect.
4. When we will report: which document will carry the interim progress and the completion.
5. The result: when the deadline arrives, the original target beside the outcome, and the reason for any gap.

Published in English on the same day as the Japanese, it lets an overseas investor judge the decision at the same time.